TNFα and response of treatment-resistant adult-onset Still's disease to thalidomide

Lancet

Volumn 352, Issue 9127, 1998, Pages 544-545

  Stambe, Cosimo ^a   Wicks, Ian P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; CD14 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR;

ADULT; ADULT ONSET STILL DISEASE; ARTICLE; CASE REPORT; DRUG RESPONSE; FEMALE; HUMAN; PRIORITY JOURNAL; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG RESISTANCE; LETTER; MONONUCLEAR CELL; PATHOLOGY; REMISSION;

ADULT; ANTIGENS, CD14; CASE-CONTROL STUDIES; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITORS; REMISSION INDUCTION; STILL'S DISEASE, ADULT-ONSET; THALIDOMIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032528622     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)79252-7     Document Type: Article

References (5)

1. 1 Klausner JD, Freedman VH, Kaplan G. Short analytical review. Thalidomide as an Anti TNF-α inhibitor: implications for clinical use. Clin Imm Immunopath 1996; 81: 219-23.
2. 2 Tseng S, Pak G, Washenik K, Pomeranz MK, Shupak JL. Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses. J Am Acad Dermatol 1996; 35: 969-79.
3. 3 Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G. Thalidomide exerts its inhibitory action on tumour necrosis alpha by enhancing mRNA degradation. J Exp Med 1993; 177: 1675-80.
4. 4 Sampaio EP, Kaplan G, Miranda A, et al. The influence of thalidomide on the clinical and immunologic manifestations of erythema nodosum leprosum. J Inf Dis 1993; 168: 408-14.
5. 5 Makonkawkeyoon S, Limson-Pobre RNR, Moreira AL, Schauf V, Kaplan G. Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Natl Acad Sci 1993; 90: 5974-78.